Activin-actrii antagonists and uses for increasing red blood cell levels

摘要

Discloses the use of an Activin-ActRII antagonist peptide which is at least 80% identical to SEQ ID NO: 2, 3, 7, 12, 16, 17, 20 or 21 in the manufacture of a medicament for treating myelodysplastic syndrome, sickle-cell disease or thalassemia.